A detailed history of Franklin Resources Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 1,753,286 shares of ITCI stock, worth $147 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,753,286
Previous 1,753,286 -0.0%
Holding current value
$147 Million
Previous $128 Million -0.0%
% of portfolio
0.04%
Previous 0.04%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$67.99 - $80.84 $10.6 Million - $12.6 Million
155,655 Added 9.74%
1,753,286 $128 Million
Q2 2024

Aug 14, 2024

SELL
$64.76 - $79.84 $1.42 Million - $1.75 Million
-21,932 Reduced 1.35%
1,597,631 $109 Million
Q1 2024

May 13, 2024

SELL
$64.37 - $75.65 $10.3 Million - $12.1 Million
-160,597 Reduced 9.02%
1,619,563 $112 Million
Q4 2023

Feb 09, 2024

SELL
$46.37 - $73.65 $366,508 - $582,129
-7,904 Reduced 0.44%
1,780,160 $127 Million
Q3 2023

Nov 13, 2023

SELL
$52.09 - $64.1 $1.05 Million - $1.29 Million
-20,165 Reduced 1.12%
1,788,064 $93.1 Million
Q2 2023

Aug 11, 2023

BUY
$54.67 - $66.44 $876,906 - $1.07 Million
16,040 Added 0.89%
1,808,229 $114 Million
Q1 2023

May 12, 2023

SELL
$43.8 - $56.99 $55,494 - $72,206
-1,267 Reduced 0.07%
1,792,189 $97 Million
Q4 2022

Feb 10, 2023

SELL
$44.07 - $54.45 $174,252 - $215,295
-3,954 Reduced 0.22%
1,793,456 $94.9 Million
Q3 2022

Nov 14, 2022

BUY
$42.7 - $59.99 $4.17 Million - $5.86 Million
97,680 Added 5.75%
1,797,410 $83.6 Million
Q2 2022

Aug 11, 2022

BUY
$43.0 - $65.64 $44,462 - $67,871
1,034 Added 0.06%
1,699,730 $97 Million
Q1 2022

May 13, 2022

BUY
$38.74 - $62.09 $23.7 Million - $38 Million
612,014 Added 56.32%
1,698,696 $104 Million
Q4 2021

Feb 11, 2022

SELL
$35.2 - $53.42 $9.78 Million - $14.8 Million
-277,977 Reduced 20.37%
1,086,682 $56.9 Million
Q3 2021

Nov 12, 2021

BUY
$28.72 - $42.49 $201 - $297
7 Added 0.0%
1,364,659 $50.9 Million
Q2 2021

Aug 13, 2021

BUY
$29.3 - $44.5 $5.75 Million - $8.73 Million
196,106 Added 16.78%
1,364,652 $55.7 Million
Q1 2021

May 13, 2021

BUY
$30.8 - $39.51 $36 Million - $46.2 Million
1,168,546 New
1,168,546 $39.6 Million
Q3 2019

Nov 14, 2019

SELL
$7.47 - $14.03 $4.59 Million - $8.62 Million
-614,700 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$10.36 - $20.96 $1.26 Million - $2.55 Million
121,600 Added 24.66%
614,700 $7 Million
Q3 2018

Nov 13, 2018

BUY
$17.77 - $22.9 $8.76 Million - $11.3 Million
493,100 New
493,100 $10.7 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.9B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.